Electrical stimulation devices market seen reaching $13.22 billion by 2030

The Business Research Company says the global market for electrical stimulation devices will grow from $9.25 billion in 2026 to $13.22 billion by 2030, driven by chronic pain treatment demand, neuromodulation adoption and minimally invasive care. North America held the largest share in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The electrical stimulation devices market is expanding as clinicians and patients look for non-pharmacological pain relief and less invasive treatment options. - The growth outlook points to more demand for devices used in chronic pain, musculoskeletal conditions and neuromodulation therapies. - The report signals where investment, product development and regional growth may concentrate through 2030.

What happened: - The Business Research Company released its Electrical Stimulation Devices Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on August 5, 2026. - The report estimates the market will rise from $8.43 billion in 2025 to $9.25 billion in 2026. - The report forecasts the market will reach $13.22 billion by 2030. - The company projects a 9.7% CAGR for 2026 and a 9.3% CAGR over the forecast period to 2030. - The report includes a free sample and full report links: Download a free sample of the market report and View the full market report.

The details: - Electrical stimulation devices are portable units that deliver mild electrical pulses through skin electrodes. - The devices are used to relieve acute postoperative pain, reduce swelling and manage chronic nerve and musculoskeletal pain. - The report cites several growth drivers, including higher prevalence of chronic pain disorders, wider adoption of neurostimulation therapies, expanded minimally invasive treatment options, improved clinical effectiveness and greater physician awareness of neuromodulation. - The forecast period is supported by growing use of personalized neuromodulation therapies, more investment in smart implantable devices, more outpatient pain management procedures, stronger remote monitoring capabilities and demand for advanced neurological treatments. - Expected market trends include broader acceptance of implantable neurostimulation devices, more use of non-invasive pain relief options, integration of intelligent control systems and more patient-specific therapies. - The report says rising muscle disorders are boosting demand because electrical stimulation can induce controlled muscle contractions using skin electrodes connected to a portable stimulator. - GOV.UK reported in January 2024 that 18.4% of people aged 16 and older in the UK had a long-term musculoskeletal condition in 2023, up from 17.6% in 2022. - The report also points to the growing preference for minimally invasive therapies, greater provider recognition of neuromodulation benefits and device advances that improve comfort and treatment effectiveness.

Between the lines: - The market story is shifting from basic pain relief toward smarter, more personalized and more connected device systems. - Faster growth in Asia-Pacific suggests room for expansion beyond mature North American demand, especially as healthcare access and adoption broaden. - The emphasis on outpatient procedures and remote monitoring suggests providers want treatments that reduce time in clinical settings.

What's next: - North America remained the largest regional market in 2025, while Asia-Pacific is expected to post the fastest growth during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The Business Research Company said its 2026 reports now include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics, and updated graphics and tables. - The company also highlighted future trend analysis and technology-focused coverage as part of the updated report format.

The bottom line: - Electrical stimulation devices are moving from a niche pain-management tool to a broader, tech-enabled treatment category with steady global demand and a strong 2030 growth forecast.